Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/05/2012 | US20120003662 Methods and Kits for Detecting Mastitis |
01/05/2012 | US20120003661 Methods and devices for the selective detection of microorganisms |
01/05/2012 | US20120003660 Diagnosis or prognosis of breast cancer based on expression level of thioredoxin-1 |
01/05/2012 | US20120003659 Strobo thin film chemical analysis apparatus and assay method using the same |
01/05/2012 | US20120003653 Compositions and methods for detecting mutations in jak2 nucleic acid |
01/05/2012 | US20120003644 Methods and kits for determining predisposition to develop kidney diseases |
01/05/2012 | US20120003643 Enrichment and identification of fetal cells in maternal blood and ligands for such use |
01/05/2012 | US20120003639 Cancer biomarkers and methods of use thereof |
01/05/2012 | US20120003638 Kit for high throughput mutation screening methods |
01/05/2012 | US20120003631 Instrument for cassette for sample preparation |
01/05/2012 | US20120003629 Biological control of nanoparticle nucleation, shape and crystal phase |
01/05/2012 | US20120003628 Methods for Diagnosing Pervasive Development Disorders, Dysautonomia and Other Neurological Conditions |
01/05/2012 | US20120003299 Novel hsp90-targeted anti-cancer chimeric peptide |
01/05/2012 | US20120003259 Molecule |
01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
01/05/2012 | US20120003244 Methods for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof |
01/05/2012 | US20120003243 Yeast ectopically expressing abnormally processed proteins and uses therefor |
01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
01/05/2012 | US20120003236 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
01/05/2012 | US20120003225 Autoantibodies in the detection and treatment of cancer |
01/05/2012 | US20120003214 Binding Moieties Based On Shark IgNAR Domains |
01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
01/05/2012 | US20120003209 Methods and kits used in identifying glioblastoma |
01/05/2012 | US20120003190 Lateral ventricle cell compositions and use for treating neural degenerative diseases |
01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
01/05/2012 | US20120003178 Evaluating the therapeutic potential of a glucan |
01/05/2012 | US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same |
01/05/2012 | US20120003157 Use of anti-90k monoclonal antibodies for the prevention and treatment of tumors and metastases thereof |
01/05/2012 | US20120003149 Novel monoclonal antibody, and use thereof |
01/05/2012 | US20120003124 Chemical analyser |
01/05/2012 | US20120003121 Sample analyzer |
01/05/2012 | US20120000275 Delivery device for dispensing pharmaceutical dosage forms into dissolution testing apparatus |
01/05/2012 | US20120000274 Ion-sensing charge-accumulation circuits and methods |
01/05/2012 | DE19907743B4 Ölqualitätssensor sowie Verfahren zu dessen Herstellung Oil quality sensor as well as methods for its preparation |
01/05/2012 | DE10340521B4 Verfahren selektiver Kapillarelektrophorese Method of selective capillary electrophoresis |
01/05/2012 | DE102010030847A1 Method for determining level in fuel tank of fuel tank system for car, involves determining volume of fuel based on measurement of flow of fuel, and determining level in fuel tank after filling based on determination of volume of fuel |
01/05/2012 | DE102010025972A1 Determining protease in biological sample, comprises converting proform of protease into active protease, contacting test sample with substrate, at which inhibitor binding substance is bound and separating substrate with protease inhibitor |
01/05/2012 | DE102010025970A1 Verfahren zur Bestimmung von Proteasen und ihren Proformen A method for the determination of proteases and their pro-forms |
01/05/2012 | DE102010025926A1 Analyseschrank sowie Verfahren zur Analyse eines insbesondere aus einem großtechnischen Prozess stammenden Messgases Analysis cabinet and method for analyzing a coming in particular from an industrial process measurement gas |
01/05/2012 | DE102010025837A1 Method for utilizing fatty acid composition and fatty acid profile from hair components for judgment of e.g. efficiency of milk cows, involves determining total fat contents and/or contents of novo synthesized fatty acid biomarkers |
01/05/2012 | DE102004050737B4 Vorrichtung zum Bestimmen des Fett- oder Ölgehaltes einer Probe Apparatus for determining the fat or oil content of a sample |
01/05/2012 | CA2837488A1 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid |
01/05/2012 | CA2806468A1 Capture of micro-organisms |
01/05/2012 | CA2805548A1 The role of fragile x mental retardation gene and protein in cancer metastasis |
01/05/2012 | CA2804205A1 Method to measure the metabolic rate or rate of glucose consumption of cells or tissues with high spatiotemporal resolution using a glucose nanosensor |
01/05/2012 | CA2803937A1 Reagents and methods for diagnosing conditions associated with hydroxylated hif 1-a |
01/05/2012 | CA2803632A1 Apparatus for disease detection |
01/05/2012 | CA2803234A1 Histone citrullinated peptides and uses thereof |
01/05/2012 | CA2803227A1 Hand-held test meter with deep power conservation mode |
01/05/2012 | CA2802347A1 Methods of kinome analysis |
01/05/2012 | CA2801946A1 Methods for manufacturing a dual biosensor test strip |
01/05/2012 | CA2800936A1 Hapten conjugates for target detection |
01/05/2012 | CA2799032A1 Methods to diagnose liver diseases |
01/04/2012 | EP2402762A1 Chloral hydrate immunoassay |
01/04/2012 | EP2402761A1 Chloral hydrate detection |
01/04/2012 | EP2402760A1 Method for determining protein solubility |
01/04/2012 | EP2402759A1 Testing strip for detecting a fluidic sample |
01/04/2012 | EP2402758A2 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
01/04/2012 | EP2402757A2 A method of enriching spermatozoa of mammals bearing X-chromosome or Y-chromosome |
01/04/2012 | EP2402756A2 Agonist anti-trkC antibodies and methods using same |
01/04/2012 | EP2402755A1 Methods and compositions for detecting Herpes simplex virus type 2 |
01/04/2012 | EP2402754A2 Unstructured recombinant polymers and uses thereof |
01/04/2012 | EP2402753A1 Analysis of sulfated polysaccharides |
01/04/2012 | EP2402752A2 A method for pharmacologically profiling compounds |
01/04/2012 | EP2402751A1 Analysis of mannosamine-containing capsular saccharides |
01/04/2012 | EP2402750A1 Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual |
01/04/2012 | EP2402749A2 Sepsis test |
01/04/2012 | EP2402748A1 Delivery device for dispensing pharmaceutical dosage forms into dissolution testing apparatus |
01/04/2012 | EP2402747A2 Analysis cabinet and method for analysing a measuring gas from a large scale process |
01/04/2012 | EP2402739A1 High-throughput optical technique for detecting biomolecular interactions |
01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
01/04/2012 | EP2402439A1 Immunization method using cancer cell |
01/04/2012 | EP2402373A2 Anti-EphB4 Antibodies and Methods Using Same |
01/04/2012 | EP2402372A2 Therapeutic agent |
01/04/2012 | EP2402370A1 Novel antibody for the diagnosis and/or prognosis of cancer |
01/04/2012 | EP2402368A1 Histone citrullinated peptides and uses thereof |
01/04/2012 | EP2402367A1 Library from toxin mutants, and methods of using same |
01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
01/04/2012 | EP2402033A1 Cell adhesion inhibitor and use thereof |
01/04/2012 | EP2402030A1 Linear IgE peptide epitopes of celery allergen api 1 |
01/04/2012 | EP2402026A2 Method for isolating hepatitis C virus peptides |
01/04/2012 | EP2401957A1 Raman spectral data analyzer, biological substance detection system, and biological substance detection method |
01/04/2012 | EP2401622A2 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor |
01/04/2012 | EP2401621A1 Use of s-erbb-3 as a marker for cancer |
01/04/2012 | EP2401620A2 Method for diagnosing vasculitis |
01/04/2012 | EP2401619A1 A method for the selective concentration of a specific low abundance biomolecule |
01/04/2012 | EP2401618A2 Methods for determine atherosclerosis regression, plaque stabilization and cardiovascular risk |
01/04/2012 | EP2401617A1 Detection of complexes of tau and amyloid |
01/04/2012 | EP2401616A1 Antigenic approach to the detection and isolation of microparticles associated with fetal dna |
01/04/2012 | EP2401615A1 Biomarkers |
01/04/2012 | EP2401614A1 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
01/04/2012 | EP2401613A2 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
01/04/2012 | EP2401612A1 Biomarkers |
01/04/2012 | EP2401611A1 Improved methods for identification |
01/04/2012 | EP2401610A1 Methods for identification |
01/04/2012 | EP2401609A2 Analyte sensor offset normalization |
01/04/2012 | EP2401608A2 System and method of temperature adjustment and control of food processing/dispensing system or apparatus |
01/04/2012 | EP2401408A2 Ovarian cancer methylome |